We are pleased to announce that we have successfully completed a Series B funding round, raising RMB 320 million (approximately USD 45 million) from a group of leading investment institutions. The funding round was co-led by Sequoia Capital China and GGV Capital, with participation from existing investors including Sinovation Ventures and Innovation Works.
The successful closing of this funding round reflects strong investor confidence in our technology leadership, manufacturing capabilities, and market growth potential within the rapidly expanding miniature motor sector, particularly driven by the explosive demand from the humanoid robotics, medical device, and high-end automation industries.
Use of Funds:
The newly raised capital will be allocated across three strategic priorities:
Priority 1 – Production Capacity Expansion (45% of funds):
We will invest approximately RMB 144 million in constructing a new, fully automated manufacturing facility in the Suzhou Industrial Park, targeting an additional annual production capacity of 1.2 million coreless motors. The new facility, spanning 25,000 square meters, will incorporate Industry 4.0 technologies including fully automated material handling systems, AI-driven quality inspection stations, and digital twin simulation for process optimization. Construction is scheduled to commence in Q1 2027, with initial production expected by Q4 2027 and full capacity ramp-up by mid-2028.
The new plant will feature specialized production lines for medical-grade and robotic-grade motors, each operating under dedicated cleanroom environments and with separate quality management protocols to meet the distinct requirements of these regulated industries.
Priority 2 – Research and Development (30% of funds):
We will allocate approximately RMB 96 million to accelerate our R&D programs, including:
- Advanced Materials Development: Investment in next-generation magnet materials including high-temperature stability and corrosion-resistant formulations.
- Driver Integration: Continued development of our SmartDrive integrated electronics platform, expanding communication protocol support and enhancing motion control algorithms.
- Ultra-Miniature Motor Development: Dedicated R&D program targeting sub-3mm diameter motors for microrobotics and microsurgical applications.
- Testing and Validation Infrastructure: Expansion of our testing laboratories with additional environmental chambers, long-term life test stations, and noise/vibration analysis equipment.
The R&D investment will also support the expansion of our engineering team, with plans to recruit 25 additional engineers over the next 18 months, specializing in electromagnetic design, power electronics, embedded firmware, and mechanical engineering.
Priority 3 – Global Market Expansion (25% of funds):
We will deploy approximately RMB 80 million to strengthen our international sales and support infrastructure:
- European Technical Center: Establishment of a new technical center in Stuttgart, Germany, providing local application engineering support, sample modification capabilities, and faster response times for European customers.
- North American Sales Expansion: Doubling our US-based sales and support team, with additional regional offices planned for Texas and California to complement our existing Chicago facility.
- Distribution Partner Network: Expansion of our authorized distributor network in Southeast Asia, India, and the Middle East, regions where we see significant growth potential in industrial automation and medical infrastructure development.
- Brand Building: Increased investment in international trade shows, industry conference participation, and digital marketing to raise our global brand profile.
Investor Perspectives:
“We have been tracking this company for several years and have been consistently impressed by their technical depth, manufacturing discipline, and customer-centric approach,” said a Managing Director at Sequoia Capital China. “As the global demand for miniature precision motors continues to surge, particularly driven by the robotics and medical device sectors, we believe this company is exceptionally well-positioned to capture meaningful market share from established international competitors.”
A Partner at GGV Capital added: “What sets this company apart is their commitment to vertical integration – from winding wire production to final assembly, they control every critical step of the manufacturing process. This not only ensures quality consistency but also provides cost advantages that are difficult for competitors to replicate. We are excited to support their global expansion journey.”
Company Milestones:
This funding milestone follows a year of significant achievements:
- Successful ISO 13485 certification for medical device manufacturing
- Carbon neutrality achievement in production operations
- Launch of the SmartDrive integrated electronics motor series
- Strategic supply agreement with a leading global robotics company
Looking Ahead:
With the Series B funding now secured, we are well-positioned to execute our growth strategy and capitalize on the exceptional market opportunities ahead. We remain committed to our mission of delivering world-class motion solutions that enable our customers to build better, more capable products.
“We are incredibly excited about the journey ahead,” said our Chief Executive Officer. “This funding round is not just about capital – it is about strategic partnerships with investors who share our vision and bring valuable networks, expertise, and global perspectives. With their support, we can accelerate our transformation from a strong regional player to a truly global leader in precision micro-drive technology.”
Post time: Jun-27-2026